[Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment].
Mikasa
K
K
D000230:Adenocarcinoma / Q000188:drug therapy / Q000276:immunology; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000276:immunology; D017291:Clarithromycin / Q000627:therapeutic use*; D016207:Cytokines / Q000378:metabolism; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D016207:Cytokines; D007155:Immunologic Factors; D017291:Clarithromycin